Remyelination in humans due to a retinoid‐X receptor agonist is age‐dependent
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51595
Abstract: Remyelination efficiency declines with advancing age in animal models, but this has been harder to demonstrate in people with multiple sclerosis. We show that bexarotene, a putatively remyelinating retinoid‐X receptor agonist, shortened the visual evoked… read more here.
Keywords: remyelination; age; retinoid receptor; remyelination humans ... See more keywords